IBUPROFEN — GRANULES, approved 2024-11-21 (ANDA091625).
211,826 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.